Related Experiment Videos
Combined oral contraceptives: a comprehensive review
Jessica Kiley1, Cassing Hammond
1Department of Obstetrics and Gynecology, Northwestern University, Chicago, Illinois 60611, USA. j-kiley@md.northwestern.edu
Clinical Obstetrics and Gynecology
|November 6, 2007
Summary
Oral contraceptives, commonly known as birth control pills, offer significant health benefits for women, including reduced risks of ovarian and endometrial cancers. Ongoing research aims to minimize potential side effects and medical risks associated with their use.
Area of Science:
- Reproductive Health
- Gynecologic Oncology
- Pharmacology
Background:
- Millions of women utilize oral contraceptives for both family planning and non-contraceptive health management.
- While rare adverse events have been documented, oral contraceptives provide established health advantages.
- These benefits include a notable reduction in the risk of developing ovarian and endometrial cancers.
Purpose of the Study:
- To highlight the established health benefits of oral contraceptives.
- To acknowledge the ongoing efforts in modifying formulations to improve safety profiles.
- To provide a balanced perspective on the use of birth control pills.
Main Methods:
- This abstract is based on a review of existing literature and clinical data regarding oral contraceptive use.
- Analysis of reported adverse events and documented health benefits.
- Examination of ongoing pharmaceutical developments in oral contraceptive technology.
Main Results:
- Oral contraceptives are associated with a decreased risk of ovarian carcinoma.
- A reduced risk of endometrial carcinoma is also a documented benefit.
- Manufacturers are actively working on formulations to mitigate side effects and medical risks.
Conclusions:
- Oral contraceptives offer significant non-contraceptive health benefits, particularly in reducing the risk of gynecologic cancers.
- Continued innovation in oral contraceptive development aims to enhance safety and tolerability.
- The benefits of oral contraceptives, when used appropriately, often outweigh the risks for many women.
Related Concept Videos
01:22Birth Control Methods
Vasectomy is a surgical form of male sterilization that involves severing and sealing the vasa deferentia, preventing sperm from mixing with semen during ejaculation. Because a vasectomy does not impact the testes' ability to produce testosterone, hormone levels, libido, and sexual function generally remain unchanged. While vasectomy is highly effective in preventing pregnancy, with a success rate near 99.85%, rare cases of recanalization (spontaneous reconnection) can occur. Although vasectomy...
01:23Oral Drug Delivery Systems: Introduction
Oral drug delivery is the most common route of administration due to its convenience, cost-effectiveness, and high patient compliance. It enables precise formulation to ensure proper drug dosage and bioavailability. The development of oral dosage forms considers drug properties such as solubility, stability, and absorption to optimize therapeutic efficacy.Tablets, capsules, liquids, and chewable formulations enhance drug stability, mask undesirable tastes, and improve patient experience.
01:26Oral Drug Delivery Systems: Continuous-Release Systems
Continuous-release drug delivery systems offer a strategic approach to maintaining therapeutic drug levels over extended periods following oral administration. By modulating the release rate of active pharmaceutical ingredients, these systems minimize fluctuations in plasma concentrations, which enhances clinical efficacy and reduces the need for frequent dosing. Such characteristics make them particularly advantageous in managing chronic diseases where patient adherence and stable drug...
01:11Oral Drug Delivery Systems: Delayed-Release Systems
Delayed-release drug delivery systems are specialized pharmaceutical formulations designed to postpone the release of active compounds until the drug reaches a specific region of the gastrointestinal (GI) tract, typically the intestine. These systems are essential for drugs that may cause gastric irritation, are unstable in acidic environments, or need to exert therapeutic effects locally in the intestinal or colonic regions.The core feature of delayed-release systems is the use of enteric...
01:30Hormonal Control of the Ovarian Cycle
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
01:22Hormonal Regulation of the Menstrual Cycle
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.